VAERS Explorer
Back to explore

Report #2837868

Received Apr 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
72 yrs
State
CO
Recovered
Unknown
Vaccinated
Apr 21, 2025
Onset
Apr 21, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
RSVRSV (AREXVY)GLAXOSMITHKLINE BIOLOGICALSUNK7942H—

Symptoms (1)

Expired product administered

Symptom narrative

Expired dose administered.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 72-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 7942H, expiry date 02-MAR-2025) for prophylaxis. On 21-APR-2025, the patient received Arexvy. On 21-APR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: Expired dose administered.). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 22-APR-2025 The pharmacist reported that a patient in their facility gave Arexvy that expired, which led to expired vaccine used. The vaccine administration facility was the same as primary reporter.